Purdue Opioid Deal May Be Worth Less Than Drugmaker Promised

(Bloomberg) -- Purdue Pharma LP’s deal to escape thousands of lawsuits over its role in the U.S. opioid crisis may provide less than half the $10 billion that the closely held drugmaker projected i...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.